Deep Braining...
TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Nutriband Inc. Warrant (NTRBW)
Nutriband Inc. Warrant
XNAS:NTRBW
1.2
-17.81%

Ask
$1.48 - 160.00
Bid
$0.01 - 100.00
Low
$
Deprecated: round(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/tendietensor/public_html/quote.php on line 381
0
High
$
Deprecated: round(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/tendietensor/public_html/quote.php on line 382
0
Open
$1.2
Prev Close
$1.46
52W High
5.25
52W Low
1
Volume
644
Avg Vol (3m)
715.89
Float

Deprecated: round(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/tendietensor/public_html/quote.php on line 389
0
Chart
TendieTensor AI Analysis

Company
Asset Type: Warrant
SIC Code: 3842
Sector: Health Technology
Industry: Medical Specialties
Date Listed: 10/01/2021
Primary Exchange: XNAS

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Phone: 407 377-6695
Address: 121 S. Orange Ave.
Address 2: Suite 1500
City: Orlando
State: FL
Postal Code: 32801
TendieTensor AI Analyst Recommendation:
Fundamentals
Total Employees:
3
P/E (TTM)
P/B (TTM)
Round Lot
100
Composit FIGI
BBG012R6YPJ8
Share Class Shares Outstanding
750,000

Technicals
RSI (14)
MACD Line
MACD Signal
SMA 20
SMA 50
EMA 50
Trend
Short Interest
Days to Cover
Higher = harder to cover
Short Interest Δ
Prev: —
Short Volume Ratio (Today)
5D avg:
Squeeze Score (0–100)
Discussion
Login to participate in discussions.
Recent News
Related Stocks

Based on the portfolios of people who own NTRBW. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.